Cyclophosphamide and liposomal-encapsulated doxorubicin (MYOCET®) in elderly women with HER-2 negative locally advanced or metastatic breast cancer: Preliminary results of a multicenter phase II trial from the Hellenic Oncology Research Group
Titel:
Cyclophosphamide and liposomal-encapsulated doxorubicin (MYOCET®) in elderly women with HER-2 negative locally advanced or metastatic breast cancer: Preliminary results of a multicenter phase II trial from the Hellenic Oncology Research Group
Auteur:
Karampeazis⁎ , A. Ardavanis, A. Kentepozidis, N. Nikolaou, Ch. Bozionelou, V. Papakotoulas, P. Tryfonidis, K. Saloustros, E. Mavroudis, D. Georgoulias, V. Vamvakas, L.